AI Summary

Researchers at MIT have devised a new method to protect CAR‑T cells from damage during freezing and transport, reducing reliance on the chemical preservative currently used. The technique aims to make CAR‑T therapy, which treats certain blood cancers, more accessible beyond the roughly 5 % of U.S. hospitals that can currently produce and deliver the cells. By improving cell preservation, the approach could enable broader distribution of the therapy to patients who otherwise require long‑distance shipment of frozen cells.

AI summaries can be wrong sometimes—always verify important details using the source article.